scAtria single-cell spatial atlas resource

NSCLC_38242124 · IMC / Imaging Mass Cytometry

NSCLC_38242124 · NSCLC_38242124__IMC

IMC / Imaging Mass Cytometry Spatial proteomics Curated Tiered

Spatial Domain (Tier 1)

951-1,000 of 2,070
Download spatial tables

Spatial Domain (Tier 1)

Dominant neighborhood compartment and purity from Tier 1 domain summaries.

2,069 ready
Sample Organ Disease state Cells Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. Domain share Purity Diversity
NSCLC_38242124__IMC__178_B5,17 Lung Primary cancer 2,293 Tumor/Malignant 28.3% 0.91 0.25
NSCLC_38242124__IMC__178_B5,18 Lung Primary cancer 3,090 Tumor/Malignant 68.3% 0.99 0.05
NSCLC_38242124__IMC__178_B5,2 Lung Primary cancer 3,944 Stromal 25.3% 0.69 0.73
NSCLC_38242124__IMC__178_B5,4 Lung Primary cancer 1,629 Stromal 32.5% 0.85 0.43
NSCLC_38242124__IMC__178_B5,5 Lung Primary cancer 1,168 Stromal 31.4% 0.45 0.92
NSCLC_38242124__IMC__178_B5,6 Lung Primary cancer 669 Tumor/Malignant 66.4% 0.98 0.07
NSCLC_38242124__IMC__178_B5,9 Lung Primary cancer 3,839 Immune 30.3% 0.47 0.75
NSCLC_38242124__IMC__178_B6,10 Lung Primary cancer 1,740 Tumor/Malignant 57.4% 0.90 0.28
NSCLC_38242124__IMC__178_B6,12 Lung Primary cancer 3,828 Immune 44.6% 0.93 0.19
NSCLC_38242124__IMC__178_B6,13 Lung Primary cancer 3,390 Stromal 34.8% 0.52 0.81
NSCLC_38242124__IMC__178_B6,14 Lung Primary cancer 3,953 Tumor/Malignant 39.8% 0.99 0.04
NSCLC_38242124__IMC__178_B6,15 Lung Primary cancer 2,326 Tumor/Malignant 45.4% 0.86 0.36
NSCLC_38242124__IMC__178_B6,17 Lung Primary cancer 1,683 Other 30.1% 0.82 0.42
NSCLC_38242124__IMC__178_B6,18 Lung Primary cancer 3,185 Tumor/Malignant 38.3% 1.00 0.05
NSCLC_38242124__IMC__178_B6,2 Lung Primary cancer 3,176 Other 24.3% 0.46 0.96
NSCLC_38242124__IMC__178_B6,3 Lung Primary cancer 2,771 Tumor/Malignant 37.4% 0.92 0.28
NSCLC_38242124__IMC__178_B6,4 Lung Primary cancer 2,586 Tumor/Malignant 69.8% 0.95 0.15
NSCLC_38242124__IMC__178_B6,5 Lung Primary cancer 3,361 Tumor/Malignant 29.6% 0.54 0.86
NSCLC_38242124__IMC__178_B6,7 Lung Primary cancer 2,274 Tumor/Malignant 63.5% 0.93 0.20
NSCLC_38242124__IMC__178_B6,8 Lung Primary cancer 685 Stromal 48.5% 0.66 0.69
NSCLC_38242124__IMC__178_B6,9 Lung Primary cancer 2,386 Stromal 30.7% 0.48 0.89
NSCLC_38242124__IMC__178_B7,10 Lung Primary cancer 3,110 Tumor/Malignant 85.7% 0.98 0.06
NSCLC_38242124__IMC__178_B7,11 Lung Primary cancer 2,791 Immune 26.8% 0.54 0.75
NSCLC_38242124__IMC__178_B7,12 Lung Primary cancer 3,185 Tumor/Malignant 66.9% 0.96 0.13
NSCLC_38242124__IMC__178_B7,13 Lung Primary cancer 553 Tumor/Malignant 45.6% 0.91 0.24
NSCLC_38242124__IMC__178_B7,14 Lung Primary cancer 2,645 Tumor/Malignant 23.8% 0.79 0.51
NSCLC_38242124__IMC__178_B7,15 Lung Primary cancer 225 Tumor/Malignant 52.0% 0.72 0.50
NSCLC_38242124__IMC__178_B7,17 Lung Primary cancer 3,390 Tumor/Malignant 50.6% 0.95 0.24
NSCLC_38242124__IMC__178_B7,18 Lung Primary cancer 2,443 Stromal 29.4% 0.36 1.04
NSCLC_38242124__IMC__178_B7,3 Lung Primary cancer 3,786 Tumor/Malignant 33.2% 0.55 0.84
NSCLC_38242124__IMC__178_B7,4 Lung Primary cancer 1,281 Stromal 26.5% 0.69 0.71
NSCLC_38242124__IMC__178_B7,5 Lung Primary cancer 2,201 Tumor/Malignant 58.7% 0.99 0.05
NSCLC_38242124__IMC__178_B7,6 Lung Primary cancer 2,414 Stromal 42.1% 0.79 0.49
NSCLC_38242124__IMC__178_B7,7 Lung Primary cancer 2,876 Tumor/Malignant 36.9% 0.89 0.40
NSCLC_38242124__IMC__178_B7,8 Lung Primary cancer 2,600 Immune 44.3% 0.95 0.11
NSCLC_38242124__IMC__178_B7,9 Lung Primary cancer 2,119 Tumor/Malignant 45.9% 0.99 0.07
NSCLC_38242124__IMC__178_B8,1 Lung Primary cancer 3,277 Other 55.3% 0.99 0.09
NSCLC_38242124__IMC__178_B8,10 Lung Primary cancer 3,527 Tumor/Malignant 87.2% 0.99 0.05
NSCLC_38242124__IMC__178_B8,11 Lung Primary cancer 2,913 Stromal 22.5% 0.77 0.57
NSCLC_38242124__IMC__178_B8,12 Lung Primary cancer 2,491 Tumor/Malignant 36.7% 0.93 0.25
NSCLC_38242124__IMC__178_B8,13 Lung Primary cancer 2,771 Tumor/Malignant 48.1% 0.93 0.24
NSCLC_38242124__IMC__178_B8,14 Lung Primary cancer 2,332 Tumor/Malignant 37.8% 0.99 0.05
NSCLC_38242124__IMC__178_B8,15 Lung Primary cancer 3,120 Tumor/Malignant 31.6% 0.85 0.35
NSCLC_38242124__IMC__178_B8,16 Lung Primary cancer 2,738 Tumor/Malignant 53.8% 0.94 0.23
NSCLC_38242124__IMC__178_B8,17 Lung Primary cancer 1,975 Tumor/Malignant 31.4% 0.73 0.66
NSCLC_38242124__IMC__178_B8,18 Lung Primary cancer 2,028 Stromal 40.5% 0.55 0.83
NSCLC_38242124__IMC__178_B8,3 Lung Primary cancer 3,681 Tumor/Malignant 31.6% 0.90 0.31
NSCLC_38242124__IMC__178_B8,4 Lung Primary cancer 2,084 Immune 27.4% 0.85 0.36
NSCLC_38242124__IMC__178_B8,5 Lung Primary cancer 28 Tumor/Malignant 64.3% 0.56 0.79
NSCLC_38242124__IMC__178_B8,6 Lung Primary cancer 4,954 Tumor/Malignant 98.5% 1.00 0.01